Dong Chen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinberg
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 46 (4) (2024)
Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinberg
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology (2024)
Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts. International journal of laboratory hematology 46 (3) (2024)
Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts. International journal of laboratory hematology (2024)
Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts. International journal of laboratory hematology 46 (3) (2024)
Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts. International journal of laboratory hematology 46 (3) (2024)
Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts. International journal of laboratory hematology 46 (3) (2024)
Dong Chen, Olga K Weinberg
Genomic alterations in blast phase of BCR::ABL1-negative myeloproliferative neoplasms. International journal of laboratory hematology (2023)